IMNN
Imunon, Inc.
There isn't enough reported data to score IMNN yet.
IMNN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Unavailable |
IMNN's revenue is currently stable, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
IMNN PE Valuation
IMNN has no meaningful PE right now: it lost money over the past year.
IMNN Forward outlook
There aren't enough analyst estimates for IMNN to show an outlook.
IMNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.26 | +$6.00 |
| Q2 2026 | -$5.78 | +$9.42 |
| Q1 2026 | -$7.39 | +$13.31 |
| Q4 2025 | -$10.75 | +$13.55 |
| Q3 2025 | -$11.26 | +$16.79 |
| Q2 2025 | -$15.20 | +$13.30 |
| Q1 2025 | -$20.70 | +$9.30 |
| Q4 2024 | -$24.30 | +$8.10 |
IMNN is still losing money, but far less than before: $5.26 per share over the past year, against $191.25 at its worst in early 2020.
IMNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $125K | 0% |
| Q3 2022 | $125K | 0% |
| Q2 2022 | $125K | 0% |
| Q1 2022 | $125K | 0% |
| Q4 2021 | $125K | 0% |
| Q3 2021 | $125K | 0% |
| Q2 2021 | $125K | 0% |
| Q1 2021 | $125K | 0% |
IMNN's revenue has held roughly level: $125,000 last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2022 | -5541% | -1149 points |
| Q3 2022 | -4940% | -890 points |
| Q2 2022 | -4783% | -726 points |
| Q1 2022 | -4674% | -367 points |
| Q4 2021 | -4393% | -558 points |
| Q3 2021 | -4049% | -722 points |
| Q2 2021 | -4057% | -244 points |
| Q1 2021 | -4307% | -494 points |
IMNN's operating margin was −5541% last quarter, down 1149 points from the same quarter a year ago, near the bottom of its range since 2019.
IMNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.2M | +$1.2M |
| Q4 2025 | -$3.7M | +$775.2K |
| Q3 2025 | -$4.4M | -$382.7K |
| Q2 2025 | -$3M | +$1.5M |
| Q1 2025 | -$3.1M | +$2.8M |
| Q4 2024 | -$4.4M | -$663.6K |
| Q3 2024 | -$4.1M | +$654.4K |
| Q2 2024 | -$4.5M | +$2.3M |
IMNN has burned cash in almost every quarter: −$14M over the past year, against −$16M the year before.
IMNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +715K shares |
| 1 year | +366% | +4.7M shares |
| 3 years | +977% | +5.4M shares |
| 5 years | +3823% | +5.8M shares |
IMNN has 6M diluted shares, up 366% from a year ago.
IMNN Net Leverage
IMNN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IMNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.1 | Oversold |
| Stochastic | 8.5 | Oversold |
IMNN's weekly RSI is 25 (oversold) and its Stochastic is 9 (oversold).
IMNN PE vs Healthcare Sector
IMNN has no meaningful PE right now: it lost money over the past year.
IMNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 39% below |
| 20 week MA | $1.41 | 55% below |
| 50 week MA | $2.36 | 73% below |
| 100 week MA | $6.65 | 90% below |
| 200 week MA | $11.7 | 95% below |
IMNN is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
IMNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $366.8 | $166.5 | -55% |
| 2021 | $166.5 | $139.5 | -16% |
| 2022 | $139.5 | $20.0 | -86% |
| 2023 | $20.0 | $10.2 | -49% |
| 2024 | $10.2 | $11.9 | +17% |
| 2025 | $11.9 | $3.15 | -74% |
| 2026 YTD | $3.15 | $0.64 | -80% |
IMNN has finished lower in five of the last six years. It's down 80% so far in 2026.